ADAR1’s restriction on ZBP1 signaling complements the mechanism of the oncogenic role of ADAR1, and developing new drugs capable of repressing ADAR1 function or directly activating ZBP1 may be the new strategy for treating cancer [33,161,182]. Here, ZBP1 is linked to cancer.